A 78-year-old male with Parkinson's disease presents with vivid visual hallucinations of people in his house. He is on carbidopa-levodopa and pramipexole. He is alert and oriented. His wife reports the hallucinations began 3 weeks after pramipexole was increased. What is the PRIORITY assessment?